Keysight Technologies, Inc. (NYSE: KEYS) today introduced Keysight AI Inference Builder (KAI Inference Builder), an emulation and analytics platform designed to validate inference ...
Morning Overview on MSN
Report: Nvidia is developing a $20B AI chip aimed at faster inference
Nvidia is reportedly developing a specialized processor aimed at accelerating AI inference, a move that could reshape how ...
Lightbits Labs Ltd. today is introducing a new architecture aimed at addressing one of the most stubborn bottlenecks in large ...
0G’s Sealed Inference takes a fundamentally different approach: privacy by code. The architecture makes unauthorized data ...
ScaleFlux, FarmGPU, and Lightbits Labs today announced the public debut of a collaborative architecture designed to solve one of AI inference's most persistent challenges: the memory and I/O ...
Nvidia's upcoming GTC conference will reveal CEO Jensen Huang's AI hardware, software, and partnership plans. Investors ...
Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...
In addition to GPUs that handle the lion's share of AI training, Nvidia wants to introduce a chip for running AI workloads on a daily basis. Thanks to the ...
SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.
Training compute builds AI models. Inference compute runs them — repeatedly, at global scale, serving millions of users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results